Supplementary Table S4 from Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
收藏NIAID Data Ecosystem2026-05-09 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S4. Comparison of the efficacy of EZH2i with inhibitors of other novel CML drug targets (4-15) in like-for-like assays.
创建时间：
2016-11-01
相关数据集
暂无相关数据集
